Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1722 participants
INTERVENTIONAL
2021-04-01
2021-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement
NCT05841810
Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination
NCT05977192
Trusted Messengers: Intervention to Promote COVID-19 Vaccination
NCT04981392
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NCT06128928
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
NCT04731870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. conduct a survey of patients to assess and track barriers, intent, and sources of information on COVID vaccine over time.
2. Determine whether a primary care physician (PCP) endorsement with or without interactive digital communication plus navigation is more effective in promoting uptake of COVID-19 vaccine than general messages from the clinic. Patients will be randomized to one of three arms:
1. Arm 1: Message about vaccine availability delivered by SMS advising patients to make an appointment.
2. Arm 2: Same as Arm 1 but delivered as a personalized message text from the PCP.
3. Arm 3: Same as Arm 2 plus a interactive 2-way SMS options.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Arm 2: Same as Arm 1 but delivered as a personalized message text from the PCP. Arm 3: Patients assigned to Arm 3 will receive the same message in the Arm 2 intervention. In addition, they will be given interactive or 2-way SMS options to obtain additional information about COVID vaccine.
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Short message service (SMS)
Subjects will receive vaccine availability and appointment information via SMS.
SMS delivery of information
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. Links to information or phone for scheduling will be provided. Messages mimic the clinic's usual practice of information delivery to patients
Personalized text message
Subjects will receive vaccine availability and appointment information via a personalized message text from the primary care provider (PCP).
Personalized text message delivery of information
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. The SMS message is personalized as a recommendation from the primary care clinician
Interactive or 2-way SMS
Subjects will receive vaccine availability and appointment information via interactive 2-way SMS options.
Interactive or 2-way SMS delivery of information
This intervention is same as in the Arm 2 using personalized messaging from the PCP. In addition, patients are given interactive or 2-way SMS options to obtain additional information about COVID vaccine and answers to frequently asked questions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMS delivery of information
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. Links to information or phone for scheduling will be provided. Messages mimic the clinic's usual practice of information delivery to patients
Personalized text message delivery of information
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. The SMS message is personalized as a recommendation from the primary care clinician
Interactive or 2-way SMS delivery of information
This intervention is same as in the Arm 2 using personalized messaging from the PCP. In addition, patients are given interactive or 2-way SMS options to obtain additional information about COVID vaccine and answers to frequently asked questions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Adelante Healthcare
UNKNOWN
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chyke A. Doubeni
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chyke Doubeni, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Scottsdale, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-002939
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.